Boston Business Journal: Mass. biopharma investment shatters records for second straight year

Jan 26, 2022

By Rowan Walrath

Originally published in Boston Business Journal on January 26, 2022

For the second straight year, the amount of venture capital that was poured into Massachusetts-based life sciences companies has eclipsed all previous fundraising records, ringing in at $13.66 billion in 2021.

According to a report from the Massachusetts Biotechnology Council, an industry group better known as MassBio, local biopharma companies accounted for 36% of all life sciences investments in the U.S., with more than 200 companies bringing in capital across some 250 rounds.

Read the full article from Boston Business Journal

See all MassBio News